Icon
Novo Nordisk
NVO
107.64
2.09%
Novo Nordisk A/S engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Diseases. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark Yahoo Finance
Download Now to Buy Novo Nordisk

Price Changes

infoIcon
-8.17%
1 Month
-9.74%
3 Months
6.35%
1 Year
1 Week
105.05
113.04
Specs
infoIcon
Min Quantity
0.01 Shares
Price Quotation
USD
Leverage
1:5
Market Cap
$513.37B
EPS (TTM)
$2.9
P/E Ratio (TTM)
39.28
Dividend Yield
1.27%
Beta (5Y, Monthly)
0.15

Trading Hours (GMT)
infoIcon
Friday
00:00 - 00:00
Saturday
00:00 - 01:00
Sunday
No Trading
Monday
01:00 - 00:00
Tuesday
00:00 - 00:00
Wednesday
00:00 - 00:00
Thursday
00:00 - 00:00
Analyst Rating
infoIcon
Strong Sell [2]
Sell [0]
Hold [2]
Buy [2]
Strong Buy [4]
80.4
Target Price
3.6
Average Score

The information presented above is for informational purposes only. It should not be interpreted as a recommendation to perform actions and/or investment advice and/or any type of consultation. You may review our KID documents here